CC1C(=O)OC2CC[N+]3(CC(=O)c4ccc(Br)cc4)CC=C(COC(=O)C(C)(O)C1(C)O)C23.[Br-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?